Metabolomics in Drug Discovery
Metabolomics is being used in Drug Discovery and in development from lead compound discovery to post approval drug surveillance. Metabolomics can help in finding potential new sites for therapeutic intervention by identifying metabolic changes. Metabolomics can provide activity information about possible novel drugs and drug scaffolds, indicate interesting targets for drug development and suggest binding partners of compounds. Furthermore, metabolomics can be used for the discovery of novel natural products and in drug development. Metabolomics can enhance the discovery and testing of new drugs and provide insight into the on- and off-target effects of drugs.
- Drug metabolism during drug design and development
- Metabolites in identification of drug targets
- Metabonomics in preclinical pharmaceutical discovery and development
- Toxicology and drug metabolism
- QSAR and ligand-receptor models
- Applications in Drug Development
Related Conference of Metabolomics in Drug Discovery
Metabolomics in Drug Discovery Conference Speakers
Recommended Sessions
- Analytical Techniques in Metabolomics
- Computational Methodologies
- Mass Spectroscopy (Ms) based Metabolomics
- Metabolic Modelling and Synthetic Biology
- Metabolomic in the field of Paediatric Medicine
- Metabolomics
- Metabolomics Applications
- Metabolomics Approaches
- Metabolomics in detection of Chemotoxicity
- Metabolomics in Discovering Biomarkers
- Metabolomics in Drug Discovery
- Metabolomics in Nutrition Research
- Metabolomics in Pharmaceutics
- Metabolomics in Precision Medicine
- Metabolomics in Systems Biology
- Metabolomics in the field Of Oncology / Cancer Metabolomic
- Metabolomics in various Diseases
- Nmr-based Metabolomics
- Pharmaco-metabolomics
- Plant and Environmental Metabolomics
- Systems Biology
Related Journals
Are you interested in
- Biochemistry - Glycobiology 2025 (Germany)
- Evolution of Glycan Diversity - Glycobiology 2025 (Germany)
- Genomics and Metabolomics - Glycobiology 2025 (Germany)
- Glycans in Diseases and Therapeutics - Glycobiology 2025 (Germany)
- Glycans in Drug Design - Glycobiology 2025 (Germany)
- Glycan’s - Glycobiology 2025 (Germany)
- Glycobiology - Glycobiology 2025 (Germany)
- Glycochemistry - Glycobiology 2025 (Germany)
- Glycoimmunology - Glycobiology 2025 (Germany)
- Glycoinformatics - Glycobiology 2025 (Germany)
- Glycolipids and Glycopeptides - Glycobiology 2025 (Germany)
- Glyconeurobiology - Glycobiology 2025 (Germany)
- Glycopathology - Glycobiology 2025 (Germany)
- Glycosience - Glycobiology 2025 (Germany)
- Proteoglycan and Sialic acid - Glycobiology 2025 (Germany)
- Recent Advances in Glycobiology - Glycobiology 2025 (Germany)
- Synthesis and Biological Role of Glycans - Glycobiology 2025 (Germany)